NO321361B1 - Cyklokarbamatderivater, deres bruk som medikament, et farmasoytisk preparat, samt anvendelse av derivatene for fremstilling av medikamenter. - Google Patents

Cyklokarbamatderivater, deres bruk som medikament, et farmasoytisk preparat, samt anvendelse av derivatene for fremstilling av medikamenter. Download PDF

Info

Publication number
NO321361B1
NO321361B1 NO20015378A NO20015378A NO321361B1 NO 321361 B1 NO321361 B1 NO 321361B1 NO 20015378 A NO20015378 A NO 20015378A NO 20015378 A NO20015378 A NO 20015378A NO 321361 B1 NO321361 B1 NO 321361B1
Authority
NO
Norway
Prior art keywords
dihydro
benzo
oxazin
dimethyl
oxo
Prior art date
Application number
NO20015378A
Other languages
English (en)
Norwegian (no)
Other versions
NO20015378D0 (no
NO20015378L (no
Inventor
III Horace FLETCHER
James P Edwards
Puwen Zhang
Eugene A Terefenko
Andrew Fensome
Jay E Wrobel
Christopher M Tegley
Todd Kevin Jones
Lin Zhi
Original Assignee
Ligand Pharm Inc
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,633 external-priority patent/US6509334B1/en
Application filed by Ligand Pharm Inc, Wyeth Corp filed Critical Ligand Pharm Inc
Publication of NO20015378D0 publication Critical patent/NO20015378D0/no
Publication of NO20015378L publication Critical patent/NO20015378L/no
Publication of NO321361B1 publication Critical patent/NO321361B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/181,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20015378A 1999-05-04 2001-11-02 Cyklokarbamatderivater, deres bruk som medikament, et farmasoytisk preparat, samt anvendelse av derivatene for fremstilling av medikamenter. NO321361B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18301299P 1999-05-04 1999-05-04
US09/552,633 US6509334B1 (en) 1999-05-04 2000-04-19 Cyclocarbamate derivatives as progesterone receptor modulators
PCT/US2000/011822 WO2000066571A1 (en) 1999-05-04 2000-05-01 Cyclocarbamate derivatives as progesterone receptor modulators

Publications (3)

Publication Number Publication Date
NO20015378D0 NO20015378D0 (no) 2001-11-02
NO20015378L NO20015378L (no) 2002-01-03
NO321361B1 true NO321361B1 (no) 2006-05-02

Family

ID=26878647

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015378A NO321361B1 (no) 1999-05-04 2001-11-02 Cyklokarbamatderivater, deres bruk som medikament, et farmasoytisk preparat, samt anvendelse av derivatene for fremstilling av medikamenter.

Country Status (19)

Country Link
EP (1) EP1173426A1 (zh)
JP (1) JP2002543193A (zh)
KR (1) KR20010114250A (zh)
CN (1) CN1145618C (zh)
AU (1) AU766428B2 (zh)
BG (1) BG106079A (zh)
BR (1) BR0010213A (zh)
CA (1) CA2371726A1 (zh)
CZ (1) CZ20013951A3 (zh)
EA (1) EA004512B1 (zh)
HU (1) HUP0201609A3 (zh)
IL (1) IL146280A0 (zh)
MX (1) MXPA01011286A (zh)
NO (1) NO321361B1 (zh)
NZ (1) NZ515355A (zh)
PL (1) PL351127A1 (zh)
SG (1) SG114650A1 (zh)
SK (1) SK15912001A3 (zh)
TR (1) TR200103286T2 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005007021D1 (de) * 2004-04-27 2008-07-03 Wyeth Corp Cyanopyrrolhaltige cyclische carbamat- und thiocarbamatbiaryle und verfahren zu deren herstellung
US20100160304A1 (en) * 2005-01-19 2010-06-24 Dainippon Sumitomo Pharma Co., Ltd Aromatic sulfone compound as aldosterone receptor modulator
WO2009044788A1 (ja) 2007-10-05 2009-04-09 Banyu Pharmaceutical Co., Ltd. ベンゾオキサジノン誘導体
CN111925353B (zh) * 2020-08-31 2022-04-08 苏州大学附属第二医院 一种2-噻吩甲腈的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
PT800519E (pt) * 1994-12-22 2004-03-31 Ligand Pharm Inc Compostos moduladores de receptores de esteroides e metodos
CA2268953A1 (en) * 1996-10-02 1998-04-09 Du Pont Pharmaceuticals Company 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same

Also Published As

Publication number Publication date
NO20015378D0 (no) 2001-11-02
EA200101176A1 (ru) 2002-04-25
KR20010114250A (ko) 2001-12-31
BR0010213A (pt) 2002-02-19
CA2371726A1 (en) 2000-11-09
TR200103286T2 (tr) 2002-07-22
CZ20013951A3 (cs) 2002-05-15
IL146280A0 (en) 2002-07-25
NO20015378L (no) 2002-01-03
CN1349517A (zh) 2002-05-15
SK15912001A3 (sk) 2002-06-04
AU766428B2 (en) 2003-10-16
HUP0201609A3 (en) 2002-12-28
MXPA01011286A (es) 2003-07-14
JP2002543193A (ja) 2002-12-17
HUP0201609A2 (en) 2002-08-28
NZ515355A (en) 2004-02-27
AU4688600A (en) 2000-11-17
BG106079A (en) 2002-05-31
SG114650A1 (en) 2005-09-28
PL351127A1 (en) 2003-03-24
CN1145618C (zh) 2004-04-14
EA004512B1 (ru) 2004-04-29
EP1173426A1 (en) 2002-01-23

Similar Documents

Publication Publication Date Title
US6566358B2 (en) Cyclocarbamate derivatives as progesterone receptor modulators
US6436929B1 (en) Cyclothiocarbamate derivatives as progesterone receptor modulators
US6444668B1 (en) Combination regimens using progesterone receptor modulators
EP1175411B1 (en) Cyclothiocarbamate derivatives as progesterone receptor modulators
EP1173210B1 (en) Contraceptive compositions containing antiprogestinic and progestinic
NO321361B1 (no) Cyklokarbamatderivater, deres bruk som medikament, et farmasoytisk preparat, samt anvendelse av derivatene for fremstilling av medikamenter.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application